Discover the latest in healthcare IT and digital health strategies at ViVE, where industry leaders converge to pioneer new solutions for patient care and system efficiency.
Related Post: HLTH USA 2025 | Oct 19-22 | Las Vegas, NV
Register
Saurabh Chaubey
Shots:
ClearStain debuted at SITC 2025 as a workflow-changing innovation, delivering high-quality virtual H&E images from unstained slides to improve tumor identification, reduce sequencing failures, preserve tissue, and accelerate molecular and precision oncology workflows
By enabling direct visualization and annotation of the exact tissue destined for sequencing, ClearStain helps pathologists and molecular labs maximize tumor purity, minimize impurities,…
Global Pharma Tech Summit 2026 is a boutique, senior-level conference designed to bring together leaders from pharma, biotech, life sciences, and digital health to explore the practical application of technology across the healthcare value chain.
The summit focuses on real-world use cases rather than sales-driven sessions, covering key areas such as AI and digital transformation…
Shots:
The 44th Annual J.P. Morgan Healthcare Conference, taking place January 12–15, 2026 in San Francisco, California, stands as the most influential healthcare investment event on the global calendar. Widely recognized as the industry’s premier forum, the conference brings together global biopharma leaders, high-growth innovators, cutting-edge technology companies, and the investment community shaping the future…
BIOCHINA2026 is coming!
Following the record-breaking success of BIOCHINA2025 with over 30,000 participants, BIOCHINA2026 will return as Asia’s largest biopharma event. Expect deeper global collaboration, cutting-edge insights, and expanded 1V1 BioPartnering sessions. From breakthrough therapies to cross-border innovation, BIOCHINA2026 continues to shape the future of biotech and pharma.
Don’t miss it, see you in Suzhou!…
The Evolution Summit is an invitation-only, premium Summit bringing leading clinical trial executives and innovative suppliers and solution providers together. The Summit’s content is aligned with key clinical trial challenges and interests, relevant market developments, and practical and progressive ideas and strategies adopted by successful pioneers.
This is an exclusive, invitation-only event. To learn more…
The PharmaMarketing Summit is an invitation-only, premium Summit bringing leading pharmaceutical marketing executives and innovative suppliers and service providers together. The Summit’s content is aligned with key pharmamarketing challenges and interests, relevant market developments, and practical and progressive ideas and strategies adopted by successful pioneers.
This is an exclusive, invitation-only event. To learn more or…
Shots:
Neurodegenerative care is at a pivotal inflection point, shifting from symptomatic relief to strategies that restore cellular resilience. Blarcamesine (ANAVEX 2-73) advances this upstream approach by activating SIGMAR1 to rebalance autophagy, targeting a core driver of neurodegeneration
Phase IIb/III findings demonstrated a statistically significant slowing of cognitive decline, with the most pronounced benefit seen in patients carrying the…
Shots:
Clinical trial sponsors are rapidly moving toward objective, continuous respiratory monitoring, adopting technologies like the RESP Biosensor to improve endpoint sensitivity, safety assessments, and real-world patient insight.
Beyond cough frequency, emerging acoustic biomarkers, such as wheezes, crackles, cough intensity, and cough bout patterns, are redefining how respiratory function and therapeutic impact are measured in modern trials.
PharmaShots welcomes Nick Delmonico,…
Shots:
Lynozyfic is emerging as a standout in heavily pre-treated multiple myeloma. In the pivotal LINKER-MM1 trial, it delivered early, deep, and durable responses, offering renewed hope for patients with limited options. Its response-adapted dosing regimen further reduces treatment burden and enhances convenience
Regeneron is accelerating progress with a broad development strategy, advancing Lynozyfic across multiple therapy lines, combination regimens, precursor conditions, and global markets. The program…